1st December 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Merck's blockbuster Januvia and Janumet on sale agitates India's Diabetes drug market

Merck Pharma commonly known as MSD in India has decided to sell its blockbuster antidiabetic drugs Januvia and Janumet. Analysts speculate top companies might be interested in the deal and the valuation might be around INR2,000 crore.

NPPA releases draft sheets for ceiling price fixation of 954 preparations

The NPPA (National Pharmaceutical Pricing Authority) has released the draft working sheets for the fixation of the ceiling prices of around 954 formulations consisting of 388 medicines, based on the database from Pharmatrac published in July’22 .

Biocon Biologics acquires Viatris Pharma for $3 billion

The biosimilars manufacturing facility of Biocon Ltd. announced the acquisition of the global biosimilars business of its partner Viatris for $3 billion. They have already paid an upfront cash of $2 billion and have issued Compulsorily Convertible Preference Shares (CCPS) of $1 billion.

Zydus Lifesciences to acquire a business facility of Watson Pharma for ₹46.77 Crore

Drug major Zydus Lifesciences Ltd. has decided to enter into a Business Transfer Agreement (“BTA”) to buy one of the business undertakings of Watson Pharma Private Limited which is involved in the research, manufacturing, marketing, and sale of APIs.

Gland pharma stocks dipped 5.4% after acquiring France-based Cenexi

According to investors, Gland pharma’s first overseas acquisition is margin dilutive and therefore might put a weight on the earnings of the company. Thus, the firm saw a 5.4 percent decline in the trading of its stock after the acquisition.

JB Pharma receives USFDA approval for Venlafaxine Extended Release tablets

On Wednesday, JB Pharma announced that their company has received USFDA approval for their ANDA (Abbreviated New Drug Application) for Venlafaxine Extended-Release Tablets 37.5 mg, 75 mg, 150 mg, and 225 mg.

Need separate pharma ministry to reduce Chinese imports: Industry CEOs

In a CEO Roundtable at the 15th CPHI & PMEC India held on Tuesday, the CEOs of pharma firms expressed the need to have a separate ministry for pharmaceuticals to encourage domestic manufacturers and reduce the dependence on Chinese imports.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?